Last reviewed · How we verify
cabergoline treatment
cabergoline treatment is a Small molecule drug developed by Istanbul Bakirkoy Maternity and Children Diseases Hospital. It is currently FDA-approved.
At a glance
| Generic name | cabergoline treatment |
|---|---|
| Sponsor | Istanbul Bakirkoy Maternity and Children Diseases Hospital |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Safety and Potency of a High Cabergoline Dosage in Microprolactinomas (PHASE3)
- Clinical Study to Evaluate Efficacy of Cabergoline to Coasting in Reducing the Incidence of Ovarian Hyperstimulation Syndrome (PHASE2)
- Cabergoline for the Treatment of Chronic Pain Due to Endometriosis (PHASE2)
- Cabergoline for Episodic Migraine (PHASE2)
- A Study on Bioequivalence of Cabergoline Tablets in Human Body (PHASE1)
- Metabolic Outcomes in Patients With Prolactinomas Under Dopamine Agonist Treatment (PHASE4)
- Cabergoline in the Management of Nonfunctioning Pituitary Adenoma (PHASE4)
- Dopamine Agonist Treatment of Non-functioning Pituitary Adenomas (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- cabergoline treatment CI brief — competitive landscape report
- cabergoline treatment updates RSS · CI watch RSS
- Istanbul Bakirkoy Maternity and Children Diseases Hospital portfolio CI
Frequently asked questions about cabergoline treatment
What is cabergoline treatment?
cabergoline treatment is a Small molecule drug developed by Istanbul Bakirkoy Maternity and Children Diseases Hospital.
Who makes cabergoline treatment?
cabergoline treatment is developed and marketed by Istanbul Bakirkoy Maternity and Children Diseases Hospital (see full Istanbul Bakirkoy Maternity and Children Diseases Hospital pipeline at /company/istanbul-bakirkoy-maternity-and-children-diseases-hospital).
What development phase is cabergoline treatment in?
cabergoline treatment is FDA-approved (marketed).
Related
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing